Overview / Abstract: |
Target Audience This activity is designed to meet the educational needs of pulmonologists, respiratory therapists, pharmacists, primary care providers, and other health care providers involved in the care of patients with and recovering from COVID-19. Program Overview This activity will cover COVID-19 and respiratory comorbidities such as acute respiratory distress syndrome and interstital lung disease. Learning Objectives Upon completion of this activity, participants should be better able to: Describe COVID-19 induced acute lung injury and ARDS |
Expiration |
Mar 02, 2022 |
Discipline(s) |
Nursing CNE, Pharmacy CPE, Physician CME, Respiratory Therapy CE |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Keywords / Search Terms |
Relias LLC FreeCME., Relias LLC., Comorbidities: ARDS & ILD Free CE CME |